No Data
No Data
No Data
No Data
No Data
Gaush Meditech Swings to Profit in 2023
Gaush Meditech (HKG:2407) recorded an attributable profit of 173.5 million yuan for 2023, rebounding from an attributable loss of 349.6 million yuan in 2022, according to the company's annual report.
MT NewswiresMay 2 20:15
高視醫療:2023年報
Futu NewsApr 29 16:43 · Announcements
Gaoshi Healthcare (02407): Zhang Bo was appointed as Joint Company Secretary
Zhitong Finance App News, Gaoshi Healthcare (02407) issued an announcement. Effective April 23, 2024: Zhang Bo has been appointed as Joint Company Secretary, effective April 23, 2024. Li Wenqi will no longer serve as joint company secretary. Effective April 23, 2024, he will still be the executive director and chief financial officer of the company.
Zhitong FinanceApr 23 20:26
Gaush Meditech Ltd's (HKG:2407) 35% Dip In Price Shows Sentiment Is Matching Revenues
Unfortunately for some shareholders, the Gaush Meditech Ltd (HKG:2407) share price has dived 35% in the last thirty days, prolonging recent pain.
Simply Wall StMar 27 06:31
GAUSH MEDITECH To Go Ex-Dividend On June 24th, 2024 With 1.1 HKD Dividend Per Share
March 26th - $GAUSH MEDITECH(02407.HK)$ is trading ex-dividend on June 24th, 2024. Shareholders of record on June 25th, 2024 will receive 1.1 HKD dividend per share on July 26th, 2024. The ex-divi
Futu NewsMar 26 17:05
Gaosi Healthcare (02407.HK) Announces Annual Results Revenue Increased by 12.2% and Has Formed a “Global 4+2” R&D Bureau
Gelonghui, March 25, 丨 Gaoshi Healthcare (02407.HK) announced that for the year ended 31 December 2023, the company's revenue was RMB 1,406.2 million, an increase of 12.2% over revenue of RMB 1,253.8 million for the year ended 31 December 2022. Net profit for the year was RMB 172.9 million (compared with a net loss of RMB 352.7 million recorded in 2022), an increase of RMB 157.3 million from adjusted net profit (non-IFRS) for the year ended 31 December 2022
Gelonghui FinanceMar 25 20:44
No Data
No Data